Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference Pharmaceutical Investing
INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on June 6, 2022 in Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. Pharmaceutical Investing
SHAREHOLDER ALERT: AUPH IRNT BKKT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Aurinia Pharmaceuticals Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GRAB, IBM and AUPH Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ERIC, ABBV and SDIG Pharmaceutical Investing
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes Pharmaceutical Investing
Health Canada Approves VRAYLAR® for the Treatment of Bipolar l Disorder and Schizophrenia in Adults Pharmaceutical Investing
Pfizer and Biohaven's VYDURA® Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine Life Science Investing
SHAREHOLDER ALERT: Weiss Law Reminds LHCG, NLSN, GDNSF, and MSP Shareholders About Its Ongoing Investigations Psychedelics Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
